Location History:
- Burlingame, CA (US) (2014)
- Carmel, IN (US) (2021)
Company Filing History:
Years Active: 2014-2021
Title: The Innovations of Carl L. Millward
Introduction
Carl L. Millward is a notable inventor based in Burlingame, California. He has made significant contributions to the field of genomics, particularly in the area of cancer prognosis and risk assessment. With a total of three patents to his name, Millward's work has the potential to impact the lives of many patients.
Latest Patents
Millward's latest patents include a gene expression profile algorithm and a test for determining the prognosis of prostate cancer. This invention provides algorithm-based molecular assays that involve measuring expression levels of genes from biological samples obtained from prostate cancer patients. The genes can be grouped into functional subsets to calculate a quantitative score that predicts the likelihood of clinical outcomes for these patients. Another significant patent involves methods for predicting cancer risk using gene expression in premalignant tissue. This disclosure provides methods for assessing a patient's cancer risk and recurrence risk by analyzing expression levels of risk genes in biological samples from the gastrointestinal tract. It also includes methods involving the V600E mutation of the BRAF gene, which is useful for assessing cancer risk and recurrence.
Career Highlights
Millward is currently associated with Genomic Health, Inc., a company that focuses on providing genomic information to improve cancer treatment decisions. His work at Genomic Health has allowed him to apply his innovative ideas in a practical setting, contributing to advancements in cancer diagnostics.
Collaborations
Some of Millward's notable coworkers include Michael R. Crager and Mark Lee. Their collaboration has likely fostered an environment of innovation and creativity, leading to the development of impactful technologies in the field of genomics.
Conclusion
Carl L. Millward's contributions to cancer prognosis and risk assessment through his innovative patents highlight his importance in the field of genomics. His work continues to pave the way for advancements that can significantly improve patient outcomes.